NovoCure Limited
US ˙ NasdaqGS ˙ JE00BYSS4X48

SecurityNVCR / NovoCure Limited
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership960,056 shares
Latest Disclosed Value $ 10,461,659
Dimensional Fund Advisors Lp reports 27.64% increase in ownership of NVCR / NovoCure Limited

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 960,056 shares of NovoCure Limited (US:NVCR) valued at $10,464,610 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 752,143 shares of NovoCure Limited. This represents a change in shares of 27.64% during the quarter. The current value of the position is $16,474,561 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F NOVOCURE ORD SHS G6674U108 960,056 207,913 27.64 10,462 7.56 0.0022
2026-02-12 2025-12-31 13F NOVOCURE ORD SHS G6674U108 752,143 186,380 32.94 9,727 33.07 0.0020
2025-11-12 2025-09-30 13F NOVOCURE ORD SHS G6674U108 565,763 539,609 2,063.20 7,310 1,471.83 0.0016
2025-08-12 2025-06-30 13F NOVOCURE ORD SHS G6674U108 26,154 847 3.35 466 3.10 0.0001
2025-05-13 2025-03-31 13F NOVOCURE ORD SHS G6674U108 25,307 -446 -1.73 452 -41.28 0.0001
2025-02-13 2024-12-31 13F NOVOCURE ORD SHS G6674U108 25,753 -3,016 -10.48 768 71.05 0.0002
2024-11-07 2024-09-30 13F NOVOCURE ORD SHS G6674U108 28,769 -895 -3.02 450 -11.61 0.0001
2024-08-09 2024-06-30 13F NOVOCURE ORD SHS G6674U108 29,664 -785 -2.58 509 6.95 0.0001
2024-05-10 2024-03-31 13F NOVOCURE ORD SHS G6674U108 30,449 -6,762 -18.17 476 -14.57 0.0001
2024-02-07 2023-12-31 13F NOVOCURE ORD SHS G6674U108 37,211 2,439 7.01 557 -1.07 0.0002
2023-11-09 2023-09-30 13F NOVOCURE ORD SHS G6674U108 34,772 -67,795 -66.10 562 -86.79 0.0002
2023-08-09 2023-06-30 13F NOVOCURE ORD SHS G6674U108 102,567 -75,264 -42.32 4,255 -60.21 0.0014
2023-05-12 2023-03-31 13F NOVOCURE ORD SHS G6674U108 177,831 12,948 7.85 10,693 89,008.33 0.0036
2023-02-09 2022-12-31 13F NOVOCURE ORD SHS G6674U108 164,883 2,543 1.57 12 -99.90 0.0036
2022-11-10 2022-09-30 13F NOVOCURE ORD SHS G6674U108 162,340 18,148 12.59 12,336 23.06 0.0047
2022-08-12 2022-06-30 13F NOVOCURE ORD SHS G6674U108 144,192 16,759 13.15 10,024 -5.07 0.0036
2022-05-13 2022-03-31 13F NOVOCURE ORD G6674U108 127,433 2,534 2.03 10,559 12.56 0.0033
2022-02-09 2021-12-31 13F NOVOCURE ORD G6674U108 124,899 2,760 2.26 9,381 -33.89 0.0028
2021-11-12 2021-09-30 13F NOVOCURE ORD G6674U108 122,139 -1,003 -0.81 14,189 -48.06 0.0046
2021-08-12 2021-06-30 13F NOVOCURE ORD G6674U108 123,142 -37,052 -23.13 27,316 29.05 0.0086
2021-05-14 2021-03-31 13F NOVOCURE ORD G6674U108 160,194 -4,120 -2.51 21,167 -25.56 0.0070
2021-03-08 2020-12-31 13F/A-2 NOVOCURE ORD G6674U108 164,314 6,883 4.37 28,434 62.29 0.0103
2021-02-11 2020-12-31 13F NOVOCURE ORD G6674U108 164,314 6,883 28,434 10,268.8495
2020-11-12 2020-09-30 13F NOVOCURE ORD G6674U108 157,431 7,232 4.81 17,520 96.74 0.0074
2020-08-13 2020-06-30 13F NOVOCURE ORD G6674U108 150,199 1,574 1.06 8,905 -11.05 0.0039
2020-05-14 2020-03-31 13F NOVOCURE ORD G6674U108 148,625 -6,013 -3.89 10,011 -23.19 0.0052
2020-02-14 2019-12-31 13F NOVOCURE ORD G6674U108 154,638 15,198 10.90 13,033 25.00 0.0047
2019-11-12 2019-09-30 13F NOVOCURE ORD G6674U108 139,440 41,164 41.89 10,426 67.81 0.0041
2019-08-13 2019-06-30 13F NOVOCURE ORD G6674U108 98,276 -45,350 -31.58 6,213 -10.18 0.0024
2019-08-12 2019-03-31 13F/A-2 NOVOCURE ORD G6674U108 143,626 143,626 6,917 0.0028
2019-05-10 2019-03-31 13F NOVOCURE ORD G6674U108 143,626 143,626 6,917
2019-02-26 2018-12-31 13F/A-1 NOVOCURE ORD G6674U108 0 -25,242 -100.00 0 -100.00
2018-11-13 2018-09-30 13F NOVOCURE ORD G6674U108 25,242 25,242 1,323 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.